QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: dmd.105.006718v1 dmd.105.006718v2 33/12/1760    most recent Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Dicke, K. E. Articles by Murphy, S. E. Search for Related Content PubMed PubMed Citation Articles by Dicke, K. E. Articles by Murphy, S. E.

SHORT COMMUNICATION

NICOTINE AND 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-BUTANONE METABOLISM BY CYTOCHROME P450 2B6

Department of Biochemistry, Molecular Biology, and Biophysics (K.E.D., S.E.M.), and The Cancer Center (K.E.D., S.M.S., S.E.M.), University of Minnesota, Minneapolis, Minnesota

Nicotine is the major addictive agent in tobacco; it is primarily metabolized by 5'-oxidation. 4-(Methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK), a potent lung carcinogen generated from nicotine during the curing of tobacco, is metabolically activated by P450 enzymes. P450 2A6 is the primary hepatic catalyst of nicotine metabolism and also catalyzes NNK -hydroxylation, albeit less efficiently. It was previously reported that P450 2B6 catalyzed nicotine 5'-oxidation. The studies presented here investigate the relative importance of P450 2B6 as a catalyst of nicotine 5'-oxidation and NNK -hydroxylation by human liver microsomes (HLMs). Radioflow high-performance liquid chromatography analysis and tritiated substrates were used to monitor the products of nicotine and NNK metabolism. The primary product of P450 2B6-catalyzed nicotine metabolism was the ^1'(5') iminium ion. The only other metabolite detected was nornicotine, the product of methyl oxidation, formed at about one-fourth the rate of the ^{1' (5')} iminium ion. We determined that P450 2B6 was a much less efficient catalyst of nicotine 5'-oxidation than previously reported, with an estimated K_m of 820 µM. In contrast, the K_m of NNK -hydroxylation was 33 µM. Experiments with P450 2A6- and P450 2B6-selective inhibitory antibodies did not support P450 2B6 as a significant catalyst of nicotine 5'-oxidation by HLMs, and it is unlikely that this enzyme contributes to nicotine metabolism in smokers who express P450 2A6. However, P450 2B6 contributed significantly to NNK metabolism in HLMs expressing both P450 2B6 and P450 2A6, suggesting a possible role for P450 2B6 in NNK metabolic activation.

This article has been cited by other articles:

				A. M. Lee, C. Jepson, P. G. Shields, N. Benowitz, C. Lerman, and R. F. Tyndale CYP2B6 Genotype Does Not Alter Nicotine Metabolism, Plasma Levels, or Abstinence with Nicotine Replacement Therapy Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1312 - 1314. [Full Text] [PDF]